Connect with us

Health

Cigarette maker BAT announces US vaccine trial launch – Medical Xpress

British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed…

Published

on

post featured image

British cigarette maker BAT said Wednesday that its US biotech division Kentucky BioProcessing will launch trials of a potential coronavirus vaccine, developed using tobacco plant technology.
The group said the US Food and Drug Administration has approved its application for a vaccine candidate, paving the way for an initial phase one clinical trial in 180 adults.
Study results are expected in mid-2021, when the group hopes to progress to a phase two trial on the project, which is being run on a…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending